课题基金 / 基金详情

Addressing important evidence gaps in the management of severe infectious diseases

Addressing important evidence gaps in the management of severe infectious diseases
解决严重传染病管理中的重要证据差距
批准号:
nhmrc : 1083105
负责人:
A/Pr Joshua Davis
金额:
$17.13万
依托单位国家:
澳大利亚
项目类别:
Career Development Fellowships
财政年份:
2015
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2015-01-01 至 2018-12-31

项目摘要

项目成果

A/Pr Joshua Davis的其他基金

相似基金

相关文献

中文摘要
翻译
目前在管理常见严重细菌感染的证据基础上存在很大的差距。我的研究计划集中在最常见的这些:金黄色葡萄球菌感染,骨和关节感染,皮肤感染和严重败血症。为了产生重要的证据来指导实践,以及发展我自己作为临床试验专家的技能和经验,我在这些领域都开展了随机对照试验。
英文摘要
There are currently large gaps in the evidence base for management of common severe bacterial infections. My research plan focuses on the most common of these: Staphylococcus aureus infections, bone and joint infections, skin infections, and severe sepsis. In order to both generate important evidence to inform practice, as well as to develop my own skills and experience as an expert in clinical trials, I have initiated randomised controlled trials in each of these areas.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Strengthening the evidence base for the management of common severe infectious diseases
  • 批准号:
    nhmrc : GNT1160331
  • 项目类别:
    Career Development Fellowships
  • 资助金额:
    $29.0万
  • 财政年份:
    2019
  • 负责人:
    A/Pr Joshua Davis
  • 依托单位:
Bacterial and Host Drivers of Fulminant Community-acquired Acinetobacter baumannii Infection
  • 批准号:
    nhmrc : 1144294
  • 项目类别:
    Project Grants
  • 资助金额:
    $49.31万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Joshua Davis
  • 依托单位:
Bacterial and Host Drivers of Fulminant Community-acquired Acinetobacter baumannii Infection
  • 批准号:
    nhmrc : GNT1144294
  • 项目类别:
    Project Grants
  • 资助金额:
    $72.93万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Joshua Davis
  • 依托单位:
CAMERA: Combination antibiotic treatment for Methicillin Resistant Staphylococcus Aureus Bacteraemia - a Randomised Controlled Trial
  • 批准号:
    nhmrc : GNT1078930
  • 项目类别:
    Project Grants
  • 资助金额:
    $111.35万
  • 财政年份:
    2015
  • 负责人:
    A/Pr Joshua Davis
  • 依托单位:
海外基金